{
    "id": "ngn_sa_priority_mission_500_112_1771349367589",
    "type": "priorityAction",
    "caseId": "tpa_contraindication_audit_01",
    "question": "The nurse has received the order to administer alteplase and has reviewed all available data in the electronic health record. Which action should the nurse take immediately?",
    "options": [
        {
            "id": "opt_4",
            "text": "Initiate the alteplase infusion and prepare for neurological checks every 15 minutes."
        },
        {
            "id": "opt_1",
            "text": "Administer an additional dose of IV labetalol to lower the systolic blood pressure below 170 mmHg."
        },
        {
            "id": "opt_2",
            "text": "Withhold the alteplase infusion and immediately notify the primary healthcare provider."
        },
        {
            "id": "opt_5",
            "text": "Ask the family to clarify the history of 'dark stools' and any recent use of NSAIDs."
        },
        {
            "id": "opt_3",
            "text": "Place a second large-bore peripheral IV catheter in the left arm."
        }
    ],
    "answer": "opt_2",
    "answerBreakdown": {
        "correct": {
            "option": "opt_2",
            "rationale": "The client's platelet count is 72,000/mm³, which is a critical finding and a contraindication for alteplase therapy (standard threshold is >100,000/mm³). Administering a thrombolytic to a client with significant thrombocytopenia poses an unacceptably high risk of severe, life-threatening intracranial or systemic hemorrhage. The nurse's primary responsibility is to recognize this safety risk, withhold the medication, and immediately communicate this critical finding to the provider."
        },
        "distractors": [
            {
                "option": "opt_1",
                "rationale": "This action is incorrect. While blood pressure control is crucial before administering alteplase, the client's current BP of 175/95 mmHg is already below the guideline threshold of <185/110 mmHg. Lowering it further is not the priority, and this action fails to address the critical contraindication of severe thrombocytopenia."
            },
            {
                "option": "opt_3",
                "rationale": "This is a reasonable preparatory action for a stroke client but is not the immediate priority. The most critical action is to prevent the harm associated with administering alteplase in the presence of a clear contraindication. Patient safety (preventing hemorrhage) supersedes procedural preparations."
            },
            {
                "option": "opt_4",
                "rationale": "This action is extremely dangerous and constitutes a major safety violation. Initiating alteplase despite the client's platelet count being well below the minimum threshold would place the client at high risk for catastrophic bleeding. This option directly ignores a critical contraindication."
            },
            {
                "option": "opt_5",
                "rationale": "While clarifying the client's history is important for a comprehensive assessment, it is not the most immediate action. The objective laboratory data (platelet count of 72,000/mm³) provides a definitive contraindication that must be addressed immediately. This action would delay the critical communication needed to ensure patient safety."
            }
        ]
    },
    "clientData": [
        {
            "type": "ehr_tabs",
            "data": [
                {
                    "id": "tab1",
                    "name": "Nurses' Notes",
                    "content": "A 68-year-old male, a migrant farmworker, presents to the ED accompanied by his adult child, who is translating. The client experienced a sudden onset of right-sided weakness and aphasia. Last known normal was 2 hours ago.\n\n**Assessment on Admission:**\nRight-sided facial droop, right arm plegia, expressive aphasia noted. NIH Stroke Scale (NIHSS) score is 12. History is limited due to the language barrier. The family reports a history of 'stomach problems' and that the client has 'dark stools sometimes' but has not sought medical care due to cost and transient work. Denies known history of hypertension, atrial fibrillation, or diabetes."
                },
                {
                    "id": "tab2",
                    "name": "Vital Signs",
                    "content": "| Time  | T (°C) | HR (/min) | RR (/min) | BP (mmHg) | SpO2 (%) |\n|-------|--------|-----------|-----------|-----------|----------|\n| 13:00 | 37.1   | 92        | 18        | 188/102   | 96 (RA)  |\n| 13:15 | 37.0   | 88        | 18        | 180/98    | 97 (RA)  |\n| 13:30 | 37.0   | 86        | 16        | 175/95    | 97 (RA)  |"
                },
                {
                    "id": "tab3",
                    "name": "Lab Results",
                    "content": "**CHEMISTRY**\n- Glucose: 110 mg/dL\n- Sodium: 138 mEq/L\n- Potassium: 4.1 mEq/L\n- BUN: 22 mg/dL\n- Creatinine: 1.3 mg/dL\n\n**HEMATOLOGY**\n- WBC: 8.9 x 10³/µL\n- Hgb: 12.1 g/dL\n- Hct: 36.8%\n- Platelet Count: **72,000/mm³**\n\n**COAGULATION**\n- PT: 12.5 seconds\n- INR: 1.1"
                },
                {
                    "id": "tab4",
                    "name": "Diagnostics",
                    "content": "**Non-Contrast Head CT Report:**\n- Findings: No evidence of acute intracranial hemorrhage, mass effect, or significant midline shift. Suspected early ischemic changes in the left middle cerebral artery (MCA) territory.\n- Impression: Findings are consistent with acute ischemic stroke; no evidence of hemorrhage."
                },
                {
                    "id": "tab5",
                    "name": "MAR",
                    "content": "**ACTIVE ORDERS:**\n- Labetalol 10 mg IV push every 10-15 minutes for SBP > 185 mmHg or DBP > 110 mmHg. (Two doses administered)\n- Alteplase (tPA) 0.9 mg/kg IV infusion over 60 minutes. Give 10% of total dose as a bolus over 1 minute. (Weight: 80 kg)\n- Initiate stroke pathway protocol.\n- Strict NPO."
                }
            ]
        }
    ]
}